Evidence map›Paper›PMID 36924661›Full record

ArticleDrug and alcohol dependence2023

The moderating role of resilience in the relationship between experiences of COVID-19 response-related discrimination and disinformation among people who inject drugs.

Angel B Algarin, Samantha Yeager, Thomas L Patterson, Steffanie A Strathdee, Alicia Harvey-Vera, Carlos F Vera, Tara Stamos-Buesig, Irina Artamanova, Daniela Abramovitz, Laramie R Smith

Abstract read
In one paragraph

Article in Drug and alcohol dependence, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Angel B AlgarinCenter for Health Promotion and Disease Prevention, Edson College of Nursing and Health Innovation, Arizona State University - Downtown Campus, Phoenix, AZ, USA.
Samantha YeagerDivision of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, CA, USA.
Thomas L PattersonDepartment of Psychiatry, University of California San Diego, San Diego, CA, USA.
Steffanie A StrathdeeDivision of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, CA, USA.
Alicia Harvey-VeraDivision of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, CA, USA; Facultad de Medicina, Universidad Xochicalco, Tijuana, Mexico; United States-Mexico Border Health Commission, Tijuana, Mexico.
Carlos F VeraDivision of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, CA, USA.
Tara Stamos-BuesigHarm Reduction Coalition of San Diego, San Diego, CA, USA.
Irina ArtamanovaDivision of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, CA, USA.
Daniela AbramovitzDivision of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, CA, USA.
Laramie R SmithDivision of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, CA, USA. Electronic address: laramie@ucsd.edu.

Funding

Ethno-epidemiology of HCV, HIV and Overdose associated with Drug Marketsand Drug TourismR01DA049644 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI STRATHDEE, STEFFANIE A. · 2020 to 2024
$8.2M
NEXUS: A novel social network approach to study the effects of intersectional stigma on HIV prevention among Latino MSMR01MH123282 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SMITH, LARAMIE RAE · 2020 to 2024
$3.5M
Addressing negative social experiences through coping and resilience to reduce methamphetamine use and improve PrEP cascade progression among Latino MSMK01DA055521 · NIDA · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI Angel B Algarin · 2022 to 2026
$943k
NIDA NIH HHS K01 DA055521NIDA NIH HHS R01 DA049644NIMH NIH HHS R01 MH123282
6 · The paper itself

Abstract

backgroundDue to the persistence of COVID-19, it remains important to measure and examine potential barriers to COVID-19 prevention and treatment to avert additional loss of life, particularly among stigmatized populations, such as people who inject drugs (PWID), who are at high risk for contracting and spreading SARS-CoV-2. We assessed the psychometrics of a novel COVID-19 response-related discrimination scale among PWID, and characterized associations between COVID-19 response-related discrimination, resilience to adversity, and endorsement of COVID-19 disinformation.

methodsWe assessed internal reliability, structural validity and construct validity of a 4-item COVID-19 response-related discrimination scale among PWID living in San Diego County, completing interviewer-administered surveys between October 2020 and September 2021. Using negative binomial regression, we assessed the relationship between COVID-19 response-related discrimination and disinformation and the potential moderating role of resilience.

resultsOf 381 PWID, mean age was 42.6 years and the majority were male (75.6 %) and Hispanic (61.9 %). The COVID-19 response-related discrimination scale had modest reliability (α = 0.66, ω = 0.66) as a single construct with acceptable construct validity (all p ≤ 0.05). Among 216 PWID who completed supplemental surveys, a significant association between COVID-19 response-related discrimination and COVID-19 disinformation was observed, which was moderated by resilience (p = 0.044). Specifically, among PWID with high levels of resilience, endorsement of COVID-19 disinformation significantly increased as exposure to COVID-19 response-related discrimination increased (p = 0.011).

conclusionsThese findings suggest that intervening on COVID-19 response-related discrimination may offset the negative outcomes associated with COVID-19 disinformation.

Indexed as

COVID-19Drug UsersHIV InfectionsSubstance Abuse, IntravenousAdultDisinformationFemaleHumansMaleReproducibility of ResultsSARS-CoV-2COVID-19DiscriminationDisinformationPeople who inject drugsPsychometricsResilience

Identifiers

PMID36924661
PMCPMC9981478

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.